Categories
- Indexing & Abstracting
- Editorial Board
- Submit Manuscript
- Instruction to Author
- Current Issue
- Past Issues
- Special Issue
- Call for papers March 2019
- Ethics and Malpractice
- Conflict of Interest Statement
- Statement of Informed Consent
- Final Proof Correction and Submission
- Publication Ethics
- Peer review process
- Cover image - February 2019
- Index Copernicus ICV 2017
- Quick Response - Contact Us
CALL FOR PAPERS
Author Information
CERTIFICATE
IMPACT FACTOR 2018
Subject Area
- Life Sciences / Biology
- Architecture / Building Management
- Asian Studies
- Business & Management
- Chemistry
- Computer Science
- Economics & Finance
- Engineering / Acoustics
- Environmental Science
- Agricultural Sciences
- Pharmaceutical Sciences
- General Sciences
- Materials Science
- Mathematics
- Medicine
- Nanotechnology & Nanoscience
- Nonlinear Science
- Chaos & Dynamical Systems
- Physics
- Social Sciences & Humanities
Why Us? >>
- Open Access
- Peer Reviewed
- Rapid Publication
- Life time hosting
- Free promotion service
- Free indexing service
- More citations
- Search engine friendly
Plagiarism Detection
IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.
The use of cell savers in orthopedic surgery
Subject Area:
Health Sciences
Abstract:
Presently, cell salvage or autologous transfusion has been incorporated in various surgeries including orthopedics. Especially in spine, hip revision and pelvic surgeries as the anticipated blood loss is always high. In this paper, we review the literature in regard to cell salvage in orthopedics surgery. In terms of indications, contraindications, cost effectiveness and complications. We performed a literature search on PubMed and included the relevant articles. We found that majority of the published literature did not prefer the routine usage of autologous transfusion mainly because it is expensive and may lead to complications. Cell salvage is preferred if the blood loss is expected to be more than 20%, the patient has a rare blood type or if the patient’s beliefs go against allogenic blood.
PDF file:
Announcement
IJMCE RECOMMENDATION
ONLINE PAYPAL PAYMENT
CURRENT ISSUE
NEWS
CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR
Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France
Monthly archive
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- 1 of 4
- ››
Advantages of IJCR
- Rapid Publishing
- Professional publishing practices
- Indexing in leading database
- High level of citation
- High Qualitiy reader base
- High level author suport
Copyright @ 2010 International Journal Of Current Research. All rights reserved
